Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew James Webb

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
British Journal of Clinical Pharmacology|April 26, 2019
Spotlight Commentary: What's new with the old drug aspirin in older adults?Andrew James Webb, Pietro Minuz
Journal of Molecular and Cellular Cardiology|February 4, 2014
Nitrite reduction and cardiovascular protectionSami A Omar, Andrew James Webb
British Journal of Clinical Pharmacology|March 6, 2019
Reply to 'Comment on 'Cardiac effects of 6 months' dietary nitrate and spironolactone in patients with hypertension and with/at risk of type 2 diabetes, in the factorial design, double-blind, randomised controlled VaSera trial' by Faconti et al.'Luca Faconti, J Kennedy Cruickshank, Andrew James Webb
British Journal of Clinical Pharmacology|February 21, 2016
It is rocket science - why dietary nitrate is hard to 'beet'! Part I: twists and turns in the realization of the nitrate-nitrite-NO pathwayJibran Khatri, Charlotte Elizabeth Mills, Perry Maskell, et al.
British Journal of Clinical Pharmacology|February 26, 2016
It is rocket science - why dietary nitrate is hard to 'beet'! Part II: further mechanisms and therapeutic potential of the nitrate-nitrite-NO pathwayCharlotte Elizabeth Mills, Jibran Khatri, Perry Maskell, et al.
British Journal of Clinical Pharmacology|January 12, 2017
Remote ischaemic preconditioning suppresses endogenous plasma nitrite during ischaemia-reperfusion: a randomized controlled crossover pilot studyAshok Nair, Sitara Khan, Sami Omar, et al.
British Journal of Clinical Pharmacology|October 9, 2018
Cardiac effects of 6 months' dietary nitrate and spironolactone in patients with hypertension and with/at risk of type 2 diabetes, in the factorial design, double-blind, randomized controlled VaSera trialLuca Faconti, Charlotte Elizabeth Mills, Virginia Govoni, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
British Journal of Clinical Pharmacology|April 26, 2019
Spotlight Commentary: What's new with the old drug aspirin in older adults?Andrew James Webb, Pietro Minuz
Journal of Molecular and Cellular Cardiology|February 4, 2014
Nitrite reduction and cardiovascular protectionSami A Omar, Andrew James Webb
British Journal of Clinical Pharmacology|March 6, 2019
Reply to 'Comment on 'Cardiac effects of 6 months' dietary nitrate and spironolactone in patients with hypertension and with/at risk of type 2 diabetes, in the factorial design, double-blind, randomised controlled VaSera trial' by Faconti et al.'Luca Faconti, J Kennedy Cruickshank, Andrew James Webb
British Journal of Clinical Pharmacology|February 21, 2016
It is rocket science - why dietary nitrate is hard to 'beet'! Part I: twists and turns in the realization of the nitrate-nitrite-NO pathwayJibran Khatri, Charlotte Elizabeth Mills, Perry Maskell, et al.
British Journal of Clinical Pharmacology|February 26, 2016
It is rocket science - why dietary nitrate is hard to 'beet'! Part II: further mechanisms and therapeutic potential of the nitrate-nitrite-NO pathwayCharlotte Elizabeth Mills, Jibran Khatri, Perry Maskell, et al.
British Journal of Clinical Pharmacology|January 12, 2017
Remote ischaemic preconditioning suppresses endogenous plasma nitrite during ischaemia-reperfusion: a randomized controlled crossover pilot studyAshok Nair, Sitara Khan, Sami Omar, et al.
British Journal of Clinical Pharmacology|October 9, 2018
Cardiac effects of 6 months' dietary nitrate and spironolactone in patients with hypertension and with/at risk of type 2 diabetes, in the factorial design, double-blind, randomized controlled VaSera trialLuca Faconti, Charlotte Elizabeth Mills, Virginia Govoni, et al.
Pageof 1